Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions

Clinical trial NCT01046214 · TERMINATED

Trial details

NCT number: NCT01046214
Sponsor: Teva Pharmaceuticals USA
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2010-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.